Among many such proteins, a well characterized distinguished drug target for SARS-Cov-2 is the 33.8 kDa, 3 C-like main protease, also called as the main protease or Nsp5 (3CLpro or Mpro or Nsp5) (Wu et al., 2020; Zhang et al., 2020).